Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Aug 8, 2014; 3(3): 37-44
Published online Aug 8, 2014. doi: 10.5409/wjcp.v3.i3.37
Preventing medication errors in neonatology: Is it a dream?
Roberto Antonucci, Annalisa Porcella
Roberto Antonucci, Annalisa Porcella, Division of Neonatology and Pediatrics, “Nostra Signora di Bonaria” Hospital, 09037 San Gavino Monreale, Italy
Author contributions: Antonucci R contributed to the study conception and design; Antonucci R and Porcella A contributed to the acquisition analysis and interpretation of data, draftinged of manuscript, critically revised the paper.
Correspondence to: Roberto Antonucci, MD, Chief, Division of Neonatology and Pediatrics, “Nostra Signora di Bonaria” Hospital, Via Roma 1, 09037 San Gavino Monreale, Italy. roant@tiscali.it
Telephone: +39-70-9378263 Fax: +39-70-9378260
Received: April 28, 2014
Revised: May 31, 2014
Accepted: July 25, 2014
Published online: August 8, 2014
Processing time: 128 Days and 14.1 Hours
Abstract

Since 1999, the problem of patient safety has drawn particular attention, becoming a priority in health care. A “medication error” (ME) is any preventable event occurring at any phase of the pharmacotherapy process (ordering, transcribing, dispensing, administering, and monitoring) that leads to, or can lead to, harm to the patient. Hence, MEs can involve every professional of the clinical team. MEs range from those with severe consequences to those with little or no impact on the patient. Although a high ME rate has been found in neonatal wards, newborn safety issues have not been adequately studied until now. Healthcare professionals working in neonatal wards are particularly susceptible to committing MEs due to the peculiarities of newborn patients and of the neonatal intensive care unit (NICU) environment. Current neonatal prevention strategies for MEs have been borrowed from adult wards, but many factors such as high costs and organizational barriers have hindered their diffusion. In general, two types of strategies have been proposed: the first strategy consists of identifying human factors that result in errors and redesigning the work in the NICU in order to minimize them; the second one suggests to design and implement effective systems for preventing errors or intercepting them before reaching the patient. In the future, prevention strategies for MEs need to be improved and tailored to the special neonatal population and the NICU environment and, at the same time, every effort will have to be made to support their clinical application.

Keywords: Medication errors, Drug safety, Adverse events, Prevention, Newborn

Core tip: Although a high medication error (ME) rate has been found in neonatal wards, newborn safety issues have not been adequately studied until now. Healthcare professionals working in neonatal wards are particularly susceptible to committing MEs due to the peculiarities of newborn patients and of the neonatal intensive care unit environment. Current neonatal prevention strategies for MEs have been borrowed from adult wards, but many factors such as high costs and organizational barriers have hindered their diffusion. The present article reviews current issues related to MEs in Neonatology and discusses the strategies to prevent them and to improve the safety of newborns.